Upper Gastrointestinal Symptoms in General Population of a District in Bangladesh

Background : Upper gastrointestinal (GI) symptoms are common complaints affecting 25--40% of the general population and are common causes of health care utilisation and substantially affect the quality of life. In day-to-day practice our clinicians have to face good number of patients with various upper GI symptoms. But we have limited data on the prevalence of different upper GI symptoms in our community. Objective : The present study aimed to find out the prevalence of different upper GI symptoms in the general population of a district in Bangladesh. Materials and Methods : This population-based observational study was conducted in a selected district of Bangladesh. Three thousand subjects selected by cluster sampling method were interviewed by a valid bowel disease questionnaire. Student’s t test and chi-square tests were used for comparison of different variables with significance level set at 0.05. Results : Among the study population 1523 were men and 1477 were women with a mean age of 33.91 ± 16.43 years. A total of 2273 (75.8%) persons had at least one upper GI symptom, 2072 (69.1%) had 2 or more symptoms and 1705 (56.8%) had 3 or more symptoms in the prior 3 months. Nine hundred sixty three subjects (32.1%) had upper abdominal pain, 1265 (42.16%) had bloating, 1354 (45.13%) had heart-burn, 1166 (38.87%) had chest pain, 1347 (44.9%) had early satiation and 258 (8.6%) had vomiting. Around 249 (8.3%, male 123, female 126, P=0.691) was diagnosed as functional dyspepsia, 187 (6.2%, male 82, female 105, P=0.059) as gastroesophageal reflux disease (GERD) and 55 (1.83%, male 27, female 28, P=0.892) as upper abdominal bloating. Only one woman fulfilled the criteria for functional gallbladder or sphincter of Oddi dysfunction. Approximately 40.56% dyspeptic patients had overlapping GERD symptoms. Symptom prevalence was found to decrease with increased number, frequency and duration of symptoms. Conclusion : Upper GI symptoms are prevalent in our community. Multiple upper GI symptoms do exist simultaneously. Symptom prevalence varies with number, frequency and duration of symptoms. DOI: http://dx.doi.org/10.3329/jemc.v4i2.19458 J Enam Med Col 2014; 4(2): 79--88

[1]  M. Masud,et al.  Prevalence and risk factors for gastro-esophageal reflux disease in the North-Eastern part of Bangladesh. , 2013, Bangladesh Medical Research Council bulletin.

[2]  M. Bortolotti.  Gastroesophageal Reflux Disease , 2012 .

[3]  L. Borgquist,et al.  The Cost of Gastro-Oesophageal Reflux Disease, Dyspepsia and Peptic Ulcer Disease in Sweden , 2012, PharmacoEconomics.

[4]  박효진.  Asian consensus report on functional dyspepsia , 2012 .

[5]  D. Sobieraj,et al.  US prevalence of upper gastrointestinal symptoms: a systematic literature review. , 2011, The American journal of managed care.

[6]  U. Ghoshal,et al.  Epidemiology of Uninvestigated and Functional Dyspepsia in Asia: Facts and Fiction , 2011, Journal of neurogastroenterology and motility.

[7]  H. Imamura,et al.  Clinical characteristics of Japanese dyspeptic patients: is the Rome III classification applicable? , 2010, Scandinavian journal of gastroenterology.

[8]  F. Schellevis,et al.  Upper gastrointestinal symptoms, psychosocial co-morbidity and health care seeking in general practice: population based case control study , 2009, BMC family practice.

[9]  Sung Won Cho,et al.  Prevalence and Risk Factors for Overlaps between Gastroesophageal Reflux Disease, Dyspepsia, and Irritable Bowel Syndrome: A Population-Based Study , 2009, Digestion.

[10]  Minhu Chen,et al.  The clinical overlap between functional dyspepsia and irritable bowel syndrome based on Rome III criteria , 2008, BMC gastroenterology.

[11]  A. Mandıracıoğlu,et al.  Overlap of symptoms of dyspepsia and gastroesophageal reflux in the community. , 2007, The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology.

[12]  W. Chey,et al.  Review article: current and emerging therapies for functional dyspepsia , 2006, Alimentary pharmacology & therapeutics.

[13]  K. Goh,et al.  Epidemiology of functional dyspepsia: a global perspective. , 2006, World journal of gastroenterology.

[14]  A. Chua.  Reassessment of functional dyspepsia: a topic review. , 2006, World journal of gastroenterology.

[15]  D. Forman,et al.  Pharmacological interventions for non-ulcer dyspepsia. , 2006, The Cochrane database of systematic reviews.

[16]  R. Heading,et al.  Heightened visceral sensation in functional gastrointestinal disease is not site-specific , 1995, Digestive Diseases and Sciences.

[17]  K. Hahm,et al.  Functional Gastrointestinal Disorders in Patients Referred to Specialist Gastroenterologists in a Tertiary Hospital , 2004 .

[18]  J. Tack,et al.  Impact of Coexisting Irritable Bowel Syndrome on Symptoms and Pathophysiological Mechanisms in Functional Dyspepsia , 2004, American Journal of Gastroenterology.

[19]  H. El‐Serag,et al.  The prevalence and clinical course of functional dyspepsia , 2004, Alimentary pharmacology & therapeutics.

[20]  N. Talley,et al.  Dyspepsia and Health Care Seeking in a Community (How Important Are Psychological Factors?) , 1998, Digestive Diseases and Sciences.

[21]  W. Wong,et al.  Prevalence, clinical spectrum and health care utilization of gastro‐oesophageal reflux disease in a Chinese population: a population‐based study , 2003, Alimentary pharmacology & therapeutics.

[22]  F. Chang,et al.  Validation of Rome II criteria for functional gastrointestinal disorders by factor analysis of symptoms in Asian patient sample , 2003, Journal of gastroenterology and hepatology.

[23]  I. Wiklund,et al.  Update on health-related quality of life in patients with gastroesophageal reflux disease , 2003, Expert review of pharmacoeconomics & outcomes research.

[24]  C. Wai,et al.  Diagnostic yield of upper endoscopy in Asian patients presenting with dyspepsia. , 2002, Gastrointestinal endoscopy.

[25]  G. Tougas,et al.  Prevalence and impact of upper gastrointestinal symptoms in the Canadian population: findings from the DIGEST study , 1999, American Journal of Gastroenterology.

[26]  D. Drossman,et al.  The functional gastrointestinal disorders and the Rome II process , 1999, Gut.

[27]  M. Camilleri,et al.  Functional gastroduodenal disorders , 1999, Gut.

[28]  Heading Rc.  Prevalence of upper gastrointestinal symptoms in the general population: a systematic review. , 1999, Scandinavian journal of gastroenterology. Supplement.

[29]  A. Haycox,et al.  The health economic impact of upper gastrointestinal symptoms in the general population: results from the Domestic/International Gastroenterology Surveillance Study (DIGEST). , 1999, Scandinavian Journal of Gastroenterology, Supplement.

[30]  G. Tougas,et al.  Prevalence and impact of upper gastrointestinal symptoms in the Canadian population: findings from the DIGEST study. Domestic/International Gastroenterology Surveillance Study. , 1999, The American journal of gastroenterology.

[31]  Talley,et al.  Efficacy of omeprazole in functional dyspepsia: double‐blind, randomized, placebo‐controlled trials (the Bond and Opera studies) , 1998, Alimentary pharmacology & therapeutics.

[32]  N. Talley,et al.  Identification of distinct upper and lower gastrointestinal symptom groupings in an urban population , 1998, Gut.

[33]  A R Zinsmeister,et al.  Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. , 1997, Gastroenterology.

[34]  K. Olden,et al.  The functional gastrointestinal disorders , 1997 .

[35]  N. Talley.  Quality of life in functional dyspepsia. , 1996, Scandinavian journal of gastroenterology. Supplement.

[36]  A. A. Azad Khan,et al.  Peptic ulcer in Bangladesh. , 1987, Bangladesh Medical Research Council bulletin.

[37]  N. Talley,et al.  Association of anxiety, neuroticism, and depression with dyspepsia of unknown cause. A case-control study. , 1986, Gastroenterology.